Legacy Wealth Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.51M Sell
2,091
-19
-0.9% -$19.4K 0.55% 36
2026
Q1
$1.94M Sell
2,110
-17
-0.8% -$17.2K 0.47% 43
2025
Q4
$2.29M Sell
2,127
-21
-1% -$20.1K 0.56% 28
2025
Q3
$1.64M Sell
2,148
-1,110
-34% -$826K 0.4% 55
2025
Q2
$2.54M Sell
3,258
-54
-2% -$42K 0.65% 26
2025
Q1
$2.74M Sell
3,312
-78
-2% -$64.9K 0.76% 18
2024
Q4
$2.62M Sell
3,390
-185
-5% -$153K 0.71% 23
2024
Q3
$3.17M Sell
3,575
-230
-6% -$207K 0.85% 14
2024
Q2
$3.44M Sell
3,805
-301
-7% -$241K 0.97% 11
2024
Q1
$3.19M Sell
4,106
-316
-7% -$225K 0.89% 13
2023
Q4
$2.58M Sell
4,422
-429
-9% -$250K 0.85% 12
2023
Q3
$2.61M Sell
4,851
-324
-6% -$167K 0.96% 10
2023
Q2
$2.43M Sell
5,175
-139
-3% -$58.3K 0.85% 13
2023
Q1
$1.82M Sell
5,314
-55
-1% -$18.5K 0.66% 29
2022
Q4
$1.96M Sell
5,369
-192
-3% -$68.1K 0.75% 21
2022
Q3
$1.8M Buy
5,561
+150
+3% +$47.5K 0.79% 19
2022
Q2
$1.75M Sell
5,411
-284
-5% -$85.2K 0.71% 23
2022
Q1
$1.63M Buy
5,695
+93
+2% +$23.9K 0.58% 31
2021
Q4
$1.55M Buy
5,602
+372
+7% +$94.3K 0.52% 33
2021
Q3
$1.21M Buy
5,230
+751
+17% +$185K 0.55% 35
2021
Q2
$1.03M Buy
4,479
+71
+2% +$14.3K 0.46% 67
2021
Q1
$824K Buy
4,408
+49
+1% +$9.59K 0.38% 91
2020
Q4
$736K Buy
+4,359
New +$651K 0.37% 97

Other funds holding LLY

Legacy Wealth Asset Management's LLY Position: Q2 2026 in Review

Legacy Wealth Asset Management reduced its Eli Lilly (LLY) stake by 0.9% in Q2 2026, selling an estimated $19.4K and leaving 2,091 shares worth $2.51M. The position accounts for 0.55% of the portfolio, ranked #36.

Legacy Wealth Asset Management first reported a position in LLY in Q4 2020 and has held it in 23 quarters since. The position peaked at $3.44M in Q2 2024. 1,844 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Legacy Wealth Asset Management held 2,091 shares of Eli Lilly worth $2.51M as of Q2 2026.
  • Legacy Wealth Asset Management sold 19 Eli Lilly shares in Q2 2026, an estimated $19.4K.
  • Eli Lilly made up 0.55% of Legacy Wealth Asset Management's portfolio in Q2 2026, its #36 holding.
  • Legacy Wealth Asset Management first reported a position in Eli Lilly in Q4 2020 and has held it in 23 quarters since.
  • Legacy Wealth Asset Management's Eli Lilly position peaked at $3.44M in Q2 2024.
  • 1,844 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Legacy Wealth Asset Management's 13F filing for Q2 2026, filed 9 Jul 2026.